🔎 Trials Near Me

ホーム › 非小細胞肺癌

米国で参加者を募集している非小細胞肺癌の臨床試験

米国全土の拠点で、非小細胞肺癌に関する429件の研究が参加者を募集しています。

最も多くの研究がある都市

州別

最近更新された研究

公式研究テキスト（英語）

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT04267848

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06623422

Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors

被験者募集中観察研究
18歳以上 · 全性別 · 2026/10/02更新 · NCT02146170

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06472245

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07293247

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07680764

Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07751042

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07365319

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06265285

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06918132

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06780085

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07513376

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07189871

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07090499

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07388524

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07155187

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06625775

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06907615

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07554339

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07190248

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。